资讯

Klotho Neurosciences, Inc. (NASDAQ: KLTO) today announced that it is moving forward with manufacturing and process ...
Corcept's main revenue driver, Korlym, helps treat hyperglycemia in adults with Cushing's Syndrome. Read why I rate CORT ...